These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 18702744)

  • 1. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
    Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
    Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
    Sikora JP; Kuzański W; Andrzejewska E
    Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
    Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation.
    Miyaoka K; Iwase M; Suzuki R; Kondo G; Watanabe H; Ito D; Nagumo M
    J Surg Res; 2005 May; 125(2):144-50. PubMed ID: 15854666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N; Low JF; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.
    Locker GJ; Kofler J; Stoiser B; Wilfing A; Wenzel C; Wögerbauer M; Steger GG; Zielinski CC; Mader R; Burgmann H
    Eur Cytokine Netw; 2000 Sep; 11(3):391-6. PubMed ID: 11022123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome.
    Vindenes HA; Ulvestad E; Bjerknes R
    Eur J Surg; 1998 Sep; 164(9):647-56. PubMed ID: 9728783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
    Gogos CA; Drosou E; Bassaris HP; Skoutelis A
    J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.
    Mwatha JK; Kimani G; Kamau T; Mbugua GG; Ouma JH; Mumo J; Fulford AJ; Jones FM; Butterworth AE; Roberts MB; Dunne DW
    J Immunol; 1998 Feb; 160(4):1992-9. PubMed ID: 9469463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokines and soluble cytokine receptors in the perioperative period].
    Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M
    Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine expression profile over time in severely burned pediatric patients.
    Finnerty CC; Herndon DN; Przkora R; Pereira CT; Oliveira HM; Queiroz DM; Rocha AM; Jeschke MG
    Shock; 2006 Jul; 26(1):13-9. PubMed ID: 16783192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
    Krohn CD; Reikerås O; Aasen AO
    Eur J Surg; 1999 Feb; 165(2):101-9. PubMed ID: 10192566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
    Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
    J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency.
    Takala A; Jousela I; Olkkola KT; Jansson SE; Leirisalo-Repo M; Takkunen O; Repo H
    Clin Sci (Lond); 1999 Mar; 96(3):287-95. PubMed ID: 10029565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?
    Slotwinski R; Olszewski WL; Slotkowski M; Lech G; Zaleska M; Slotwinska SM; Krasnodebski WI
    JOP; 2007 Nov; 8(6):759-69. PubMed ID: 17993728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.